PRTG Stock Summary and Trading Ideas (Portage Biotech | NASDAQ:PRTG)

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Portage Biotech trades on the NASDAQ stock market under the symbol PRTG.

As of January 17, 2025, PRTG stock price climbed to $4.10 with 164,059 million shares trading.

PRTG has a market cap of $4.60 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PRTG traded as high as $239.80 and as low as $2.10.

PRTG has underperformed the market in the last year with a price return of -81.0% while the SPY ETF gained +28.0%. PRTG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.9% and -17.7%, respectively, while the SPY returned +3.0% and +1.0%, respectively.

PRTG support price is $3.46 and resistance is $4.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRTG shares will trade within this expected range on the day.